Induction of Thrombosis in a Mouse Model by IgG, IgM and IgA Immunoglobulins from Patients with the Antiphospholipid Syndrome

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266

Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders

Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095

Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia

Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Matsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., & Koike, T. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.2.457 · Cited by 528

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526

The Catastrophic Antiphospholipid Syndrome

Rodríguez‐Pintó, I., Espinosa, G., & Cervera, R. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_20 · Cited by 493

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]

Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., & de Groot, P. G. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 487

Immunology and clinical importance of antiphospholipid antibodies

McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

Blank, M., Cohen, J., Toder, V., & Shoenfeld, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3069 · Cited by 453

Anti-phospholipid Antibodies

Harris, E. N., Gharavi, A. E., & Hughes, G. R. V. (1985) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00606-8 · Cited by 442

New targeted therapies for treatment of thrombosis in antiphospholipid syndrome

Pierangeli, S. S., Vega-Ostertag, M. E., & González, E. B. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000506 · Cited by 31

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)

Savelli, S., Roubey, R. A. S., Kitzmiller, K. J., Zhou, D., Nagaraja, H. N., Mulvihill, E., Barbar-Smiley, F. A., Ardoin, S. P., Wu, Y. L., & Yu, C. Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00885 · Cited by 33

Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients

Shen, H., Li, R., Xiao, H., Zhou, Q., Cui, Q., & Chen, J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.09.009 · Cited by 30

Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies

Gharavi, A. E., Vega-Ostertag, M. E., Espinola, R. G., Liu, X., Cole, L., Cox, N., Romagnoli, P. A., Labat, K., & Pierangeli, S. S. (2004) · Lupus · doi:10.1191/0961203304lu484oa · Cited by 29

Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?

Chayouâ, W., Yin, D., Kelchtermans, H., Moore, G. W., Gris, J., Musiał, J., Zuily, S., Cate, H. T., de Laat, B., & Devreese, K. M. J. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1714653 · Cited by 30

Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess

Pérez, D., Tincani, A., Serrano, M., Shoenfeld, Y., & Serrano, A. (2017) · Lupus · doi:10.1177/0961203317738227 · Cited by 28

IgA Anticardiolipin and Anti-??2-Glycoprotein I Are the Most Prevalent Isotypes in African American Patients with Systemic Lupus Erythematosus

Cucurull, E., Gharavi, A. E., Diri, E., Méndez, E., Kapoor, D., & Espinoza, L. R. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199907000-00009 · Cited by 28

Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies

Chukwuocha, R. U., Zhu, M., Cho, C. S., Visvanathan, S., Hwang, K. K., Rahman, A., & Chen, P. P. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00115-3 · Cited by 28

Pharmacodynamic effects of Dan-hong injection in rats with blood stasis syndrome

Bi, C., Li, P., Liao, Y., Rao, H., Li, P., Yi, J., Wang, W.-Y., & Su, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109187 · Cited by 27

Anticardiolipin and anti-beta-2-glycoprotein I antibodies

Marai, I., Tincani, A., Balestrieri, G., & Shoenfeld, Y. (2005) · Autoimmunity · doi:10.1080/08916930400022608 · Cited by 27

Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome

Yang, L., Guo, R., Liu, H., Chen, B., Li, C., Liu, R., Liao, S., Xie, Q., & Yin, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1527554 · Cited by 28

Acquired and Inherited Thrombophilia Disorders in Pregnancy

Pierangeli, S. S., Leader, B., Barilaro, G., Willis, R., & Branch, D. W. (2011) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2011.02.016 · Cited by 25

The Effects of NF-κB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-β2GPI in Mouse

Xia, L., Xie, H., Yu, Y., Zhou, H., Wang, T., & Yan, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147958 · Cited by 24

Primary, Secondary, Catastrophic Antiphospholipid Syndrome: is there a difference?

Harris, E. N., & Pierangeli, S. S. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.003 · Cited by 24

Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome

Urbanski, G., Caillon, A., Poli, C., Kauffenstein, G., Bégorre, M.-A., Loufrani, L., Henrion, D., & Belizna, C. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206814 · Cited by 23

Collagen-induced thrombosis in murine arteries and veins

Cooley, B. C. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.019 · Cited by 23

Antiphospholipid Antibodies and Cerebral Lupus

Harris, E. N., & Pierangeli, S. S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48400.x · Cited by 21

True anti‐anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity

Gallart, T., Benito, C., Reverter, J. C., Bosch, F., Blay, M., Tàssies, D., Vigorito, E., Cervera, R., Font, J., Gomis, R., et al. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2002.03335.x · Cited by 21

3 Acquired thrombophilia

Girling, J., & de Swiet, M. (1997) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(97)80021-1 · Cited by 21

Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: Implications for the pathogenesis of preeclampsia

Chen, Q., Guo, F., Hensby-Bennett, S., STONE, P. R., & Chamley, L. (2012) · Placenta · doi:10.1016/j.placenta.2012.07.019 · Cited by 20

Electric injury model of murine arterial thrombosis

Kusada, A., Isogai, N., & Cooley, B. C. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.03.005 · Cited by 20

Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia

Öztürk, M. A., Haznedaroğlu, İ. C., Turgut, M., & Göker, H. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000201 · Cited by 19

Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers

Chaturvedi, S., & McCrae, K. R. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0668-2 · Cited by 17

Inflammation and thrombosis new insights

Myers, D. D. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s289 · Cited by 16

Anti‐β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model

Forastiero, R. R., Martinuzzo, M. E., Larrañaga, G. F. D., Vega-Ostertag, M. E., & Pierangeli, S. S. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04197.x · Cited by 15

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome

Efthymiou, M., Arachchillage, D. J., Lane, P. J., O’Keeffe, A. G., McDonnell, T. C. R., Cohen, H., & Mackie, I. J. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.08.003 · Cited by 15

In Vivo Models of Thrombosis

Chi, L., Rebello, S. S., & Lucchesi, B. R. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-59942-2_4 · Cited by 15

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Diaz, J. A., Wrobleski, S. K., Hawley, A. E., Lucchesi, B. R., Wakefield, T. W., & Myers, D. D. (2011) · Journal of Visualized Experiments · doi:10.3791/2737-v · Cited by 14

ANIMAL MODELS FOR ANTIPHOSPHOLIPID SYNDROME IN PREGNANCY

Ziporen, L., Blank, M., & Shoenfeld, Y. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70317-3 · Cited by 14

Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Cohen, H., Werring, D. J., Chandratheva, A., Mittal, P., Devreese, K. M. J., Isenberg, D. A., Amoura, Z., ANDRADE, D. C. O. D., Baccouche, H., Baldwin, N., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.06.020 · Cited by 11

Use of Mouse Models to Study Plasminogen Activator Inhibitor-1

Declerck, P. J., Gils, A., & Taeye, B. M. D. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-386471-0.00005-5 · Cited by 12

Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis

Shinzato, M. M., Bueno, C., Viana, V. S. T., Borba, E. F., Gonçalves, C. R., & Bonfá, E. (2005) · Lupus · doi:10.1191/0961203305lu2252oa · Cited by 11

Antiphospholipid Antibodies: Laboratory and Pathogenetic Aspects

Vlachoyiannopoulos, P. G., Samarkos, M., Sikara, M. P., & Tsiligros, P. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360601079549 · Cited by 12

Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand?

Marchetti, T., Cohen, M., Gris, J., & de Moerloose, P. (2013) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2025 · Cited by 11

Anti‐cardiolipin from periodontitis patients induces MCP ‐1 production by human umbilical vein endothelial cells

Schenkein, H. A., Sabatini, R., Koertge, T. E., Brooks, C. N., & Purkall, D. B. (2012) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12043 · Cited by 11

The Contribution of Experimental Models to our Understanding of Etiology, Pathogenesis and Novel Therapies in the Antiphospholipid Syndrome

Blank, M., Krause, I., & Shoenfeld, Y. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_38 · Cited by 11

Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for ‘seronegative’ diagnosis

Capozzi, A., Riitano, G., Mancuso, S., Recalchi, S., Manganelli, V., Garofalo, T., Alessandri, C., Longo, A., Misasi, R., Conti, F., et al. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13633 · Cited by 10

The Antithrombotic Effect of Recombinant Neorudin on Thrombi

Liu, Y., Zhang, L., Zhou, X., Zhou, Y., Liu, Y., Zheng, C., Xu, X., Geng, P., Hao, C., Zhao, Z., et al. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s353088 · Cited by 10

Serum Anticardiolipin Concentrations in Patients With Chronic Periodontitis Following Scaling and Root Planing

Chaston, R., Sabatini, R., Koertge, T. E., Brooks, C. N., & Schenkein, H. A. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.130408 · Cited by 9

Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome

Weiss, R., Bitton, A., Nahary, L., Arango, M., Benhar, I., Blank, M., Shoenfeld, Y., & Chapman, J. (2016) · Immunologic Research · doi:10.1007/s12026-016-8840-8 · Cited by 9

Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody

Fischer, C., Buschmann, K., Blank, M., STACHL, A., Miesbach, W., Shoenfeld, Y., Lackner, K. J., & von Landenberg, P. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.08.001 · Cited by 9

Standardization of a well-controlled in vivo mouse model of thrombus formation induced by mechanical injury

Tang, C., Wang, Y., Lei, D., Huang, L., Wang, G., Chi, Q., Zheng, Y., Gachet, C., Mangin, P., & Zhu, L. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.02.032 · Cited by 8

Silvia Pierangeli, PhD (1955–2013)

Harris, E. N., & Willis, R. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1368795 · Cited by 8

Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women

Todorova, M., Kamenov, Z. A., Baleva, M. P., Christov, V. G., & Nicolov, K. (2004) · Maturitas · doi:10.1016/j.maturitas.2003.10.009 · Cited by 8

The Structure and Derivation of Antibodies and Autoantibodies

Franchin, G., Zou, Y.-R., & Diamond, B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00008-x · Cited by 8

Effect of Age on the Protein Profile of Healthy Malay Adults and its Association with Cognitive Function Competency

Bakar, Z. H. A., Damanhuri, H. A., Makpol, S., Aizat, W. M., Sani, N. F. A., Hamzah, A. I. Z. A., Aripin, K. N. N., Rani, M. D. M., Noh, N. A., Razali, R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180511 · Cited by 8

Síndrome antifosfolípido: estado actual

Santor, J. E. A., Galiana, L. I., & Paredes, G. P. (2007) · Anales de Medicina Interna · doi:10.4321/s0212-71992007000500009 · Cited by 7

Anticardiolipin Antibodies and Risk of Thromboembolic Disease in Young Jamaican Women

Kahwa, E., Sargeant, L. A., McFarlane‐Anderson, N., Smikle, M. F., Forrester, T., & Wilks, R. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800603 · Cited by 7

Detection of cerebral microembolic signals by transcranial Doppler may be a useful part of the equation in determining stroke risk in patients with antiphospholipid antibody syndrome

Brey, R. L., & Carolin, M. (1997) · Lupus · doi:10.1177/096120339700600801 · Cited by 7

Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Tests

Bertolaccini, M. L., Amengual, O., Artim-Esen, B., Atsumi, T., de Groot, P. G., de Laat, B., Devreese, K. M. J., Giles, I., Meroni, P. L., Borghi, M. O., et al. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_8 · Cited by 6

Antibody-mediated thrombosis: Relation to the antiphospholipid syndrome

Vermylen, J., Geet, C. V., & Arnout, J. (1998) · Lupus · doi:10.1177/096120339800700215 · Cited by 6

A Preclinical Porcine Model of Portal Vein Thrombosis in Liver Cirrhosis

Zhang, R., Lu, S., Jiang, Y., Ma, J., Zhang, W., Gu, J., Wang, J., & Chen, S. (2020) · BioMed Research International · doi:10.1155/2020/3086906 · Cited by 5

IgA anti-beta-2 glycoprotein I antibodies in chronic hepatitis C

Melayah, S., Kallala, O., Ahmed, M. B., Fodha, I., Jemni, S. Y., Ghédira, I., & Mankaï, A. (2022) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2021.12.003 · Cited by 5

Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study

Su, Z., Huang, Z., Zhao, J., Li, M., Hu, J., Zeng, X., Hu, C., & Yang, B. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221081129 · Cited by 5

Pathogenic Mechanisms of Thrombosis in Antiphospholipid Syndrome (APS)

Marina, P., Eleftheria, P., & Panayiotis, G. (2011) · InTech eBooks · doi:10.5772/25522 · Cited by 5

Antiphospholipid Syndrome

Avčin, T., & O’Neil, K. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00024-7 · Cited by 5

Anti‐Cardiolipin and Anti‐β2‐Glycoprotein I Antibodies

Andréoli, L., Malacarne, F., Ceribelli, A., KUTSCHERA, I., & Tincani, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.059 · Cited by 5

Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis

Willis, R., Cohen, H., Giles, I., Knight, J. S., Krilis, S. A., Rahman, A., & de Groot, P. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_5 · Cited by 5

Pathophysiological insights into the antiphospholipid syndrome

Manukyan, D., Müller‐Calleja, N., & Lackner, K. J. (2016) · Hämostaseologie · doi:10.5482/hamo-16-07-0020 · Cited by 4

Definition and Epidemiology of Antiphospholipid Syndrome

Ünlü, O., Domingues, V., de Jesús, G. R., Zuily, S., Espinosa, G., Cervera, R., Levy, R. A., Wahl, D. G., Erkan, D., & Lockshin, M. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_7 · Cited by 4

The Antiphospholipid Syndrome

Roubey, R. A. S. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-703-1_29 · Cited by 4

Antiphospholipid antibodies and stroke†

SHANAHAN, J., & Ortel, T. L. (2002) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/scds.2002.124067 · Cited by 4

Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation

Albay, A., Artım-Esen, B., Pericleous, C., Wincup, C., Giles, I., Rahman, A., & McDonnell, T. C. R. (2019) · Lupus · doi:10.1177/0961203319851571 · Cited by 4

Two cases of livedo vasculopathy with non‐criteria antiphospholipid antibodies

Hasegawa, M., Fujimoto, M., Orito, H., Matsushita, T., Hamaguchi, Y., & Takehara, K. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01664.x · Cited by 3

Progress in the field of animal models of antiphospholipid syndrome

Gao, X., Ma, D., Mi, L., Zhao, J., An, Q., Guo, Z., Yang, B., Zhang, L., & Xu, K. (2024) · Autoimmunity · doi:10.1080/08916934.2024.2391350 · Cited by 3

Anticyclic citrullinated peptide antibodies: the footprint of autoreactive plasma cells in synovium?

Teng, Y. K. O., & van Laar, J. M. (2007) · Future Rheumatology · doi:10.2217/17460816.2.6.577 · Cited by 3

A Comprehensive Review of Thrombogenic Mechanisms in APS

Aguilar‐Valenzuela, R., Martínez-Martínez, L.-A., & Pierangeli, S. S. (2010) · The Open Autoimmunity Journal · Cited by 3

Inflammation and Hemostatic Activation may Contribute to Postsurgical Thrombosis in Patients With Bladder Cancer

Abro, S., Clark, M., Barkan, G. A., Hoppensteadt, D., Fareed, J., Wojick, E., & Quek, M. L. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615622000 · Cited by 3

Anti-phospholipid Syndrome

Erkan, D., Salmon, J. E., & Lockshin, M. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00082-6 · Cited by 3

Antibodies to Cardiolipin and other Phospholipids

Pierangeli, S. S., & Harris, E. N. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50006-1 · Cited by 3

The regulatory roles of Beta-2 glycoprotein I (β2GPI) in thrombosis and hemostasis and abnormal disease conditions developed by autoantibodies against β2GPI

Wang, R., Tan, X. W., Yu, C., Li, M., Wang, S., Yuan, B., Ma, X., Liu, Q., Matsuura, E., & Shen, L. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103984 · Cited by 2

Chapter 3 Laboratory Heterogeneity of Antiphospholipid Antibodies

Pierangeli, S. S., & Rand, J. H. (2009) · Technical report · doi:10.1016/s1571-5078(08)00403-0 · Cited by 2

Perinatal Implications of the Antiphospholipid Syndrome

Smith, J. F., & Druzin, M. L. (2007) · NeoReviews · doi:10.1542/neo.8-5-e206 · Cited by 2

Autoantikörper bei rheumatischen Erkrankungen

Burkhardt, H., & Voll, R. E. (2003) · Springer eBooks · doi:10.1007/978-3-642-55803-0_7 · Cited by 2

Anticardiolipin Testing

Pierangeli, S. S. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_23 · Cited by 2

Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Abdelwahab, M., Kiefer, M. K., & Costantine, M. M. (2024) · Wiley eBooks · doi:10.1002/9781119820260.ch50 · Cited by 2

Expression of host defense scavenger receptors in spondylarthropathy

McBeth (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200104)44:4 · Cited by 1

Antiphospholipid Antibody-Induced Pregnancy Loss and Thrombosis

Girardi, G., & Salmon, J. E. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_31 · Cited by 1

IgA Anticardiolipin in Patients with Gastroenteric Tumor

Bernardini, I., Pugliese, L., Pacifico, E., Viola-Magni, M., & Albi, E. (2009) · Scholarly Research Exchange · doi:10.3814/2009/641360 · Cited by 1

Syndrome des antiphospholipides

Meyer, O. (2010) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(10)52466-5 · Cited by 1

Antibodies and Diagnostic Tests in Antiphospholipid Syndrome

Chighizola, C. B., Borghi, M. O., & Meroni, P. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00057-7 · Cited by 1

Evidence of Thrombogenesis Recurrence Induced by IgA Antiphospholipid Antibody β2 Glycoprotein I-Dependent in Early Adulthood

Yacoub, M. S., Khine, J., Najar, A., & Yadlapalli, S. (2022) · Cureus · doi:10.7759/cureus.23535 · Cited by 1

Antiphospholipid Syndrome

Erkan, D., Salmon, J. E., & Lockshin, M. D. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10076-2 · Cited by 1

Persistent Moderate-to-High Levels of Isolated Anticardiolipin Antibody IgA or Anti-β2-Glycoprotein-I IgA Isotypes: Do They Have Any Clinical Relevance?

Dinçer, A. B. K., Thaler, J., & Erkan, D. (2024) · Turkish Journal of Hematology · doi:10.4274/tjh.galenos.2024.2024.0068 · Cited by 1

Investigation the complement level in abortive women with antiphospholipid syndrome

Salih, M. B. (2014) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/v4i3.628 · Cited by 1

Overview of the Last 25 Years and 13 International Congresses on Antiphospholipid Antibodies

Harris, E. N., & Pierangeli, S. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3194-7_1 · Cited by 1

Anticardiolipin Antibodies In Spontaneously Hypertensive Rats (Shr), Stroke‐Prone Shr And Normal Wistar Rats

Todorova, M. S., Baleva, M., Nikolov, K. V., Higashino, H., & Kamenov, Z. A. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03316.x · Cited by 1

B Cells and Generation of Antibodies

Atisha‐Fregoso, Y., Zou, Y.-R., & Diamond, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00009-8 · Cited by 1

B-Cell Targeted Therapies in Autoimmune Cytopenias and Thrombosis

Matta, B. N., Nayfe, R., Taher, A. T., & Uthman, I. W. (2013) · Milestones in drug therapy · doi:10.1007/978-3-0348-0706-7_11 · Cited by 1

Antibodies and diagnostic tests in antiphosholipid syndrome

Chighizola, C. B., Borghi, M. O., & Meroni, P. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00059-3 · Cited by 2

Recent Insights into the Molecular and Cellular Contributions to Venous Thrombosis

Henke, P. K., Diaz, J. A., Myers, D. D., & Wakefield, T. W. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-906-8_3 · Cited by 1

One-Step Separation of IgG Subclasses of DNA Hydrolyzing Autoantibodies: A Study on Sera of Patients with Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome by Histidine Ligand Affinity Chromatography

Elkakz, A., Matta, H., & Uzun, L. (2008) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826060701884079 · Cited by 1

Antiphospholipid Syndrome

Branch, D. W., & Lockshin, M. (2005) · Technical report · doi:10.1016/s1571-5078(05)04006-7 · Cited by 1

Molecular Pathogenesis of the Antiphospholipid Syndrome: Toward Novel Therapeutic Targets

Pierangeli, S. S., Vega-Ostertag, M. E., Gharavi, A. E., & Harris, E. N. (2006) · Springer eBooks · doi:10.1007/0-387-24534-0_26

Antiphospholipid Syndrome - An Evolving Story of a Multisystemic Disease

Silvia, S., Willis, R., Harper, B. E., & Manoharan, E. N. E. A. (2012) · InTech eBooks · doi:10.5772/36714

Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Porter, T. F., & Branch, D. W. (2010) · Wiley eBooks · doi:10.1002/9781444316780.ch36

Anticardiolipin antibodies as markers of physiologic stress: a case study of idiopathic stroke in a young adult

Segler, C. P. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.036

A Case of Primary Antiphospholipid Antibody Syndrome with Multiple Thromboses Including Thrombotic Occlusion of Abdominal Aorta

Ko, J. Y., Lee, S. H., Kim, J., Lee, B., Yoo, B. S., Choe, K. H., & Yoon, J. (2001) · Korean Circulation Journal · doi:10.4070/kcj.2001.31.7.707

Importance des anticorps antiphospholipides en clinique

HACHULLA, E. (2001) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/s0923-2532(01)80061-2

Identification of anti-beta₂ glycoprotein I auto-antibody regulated gene targets in the primary antiphospholipid syndrome using gene microarray analysis

Hamid, C. (2007)

Thrombogenic Properties of Murine Anti-Cardiolipin Antibodies Induced by β 2 Glycoprotein 1 and Human Immunoglobulin G Antiphospholipid Antibodies

Pierangeli, S. S., Liu, X. W., Anderson, G., Barker, J. H., & Harris, E. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1746 · Cited by 118

In Vivo Models of Thrombosis for the Antiphospholipid Syndrome

Pierangeli, S., & Harris, E. N. (1996) · Lupus · doi:10.1177/096120339600500524 · Cited by 65

Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice

Pierangeli, S. S., Barker, J. H., Stikovac, D., Ackerman, D., Anderson, G. L., Barquinero, J., Acland, R. D., & Harris, E. N. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642501 · Cited by 138

β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model

Arad, A., Proulle, V., Furie, R. A., Furie, B. C., & Furie, B. (2011) · Blood · doi:10.1182/blood-2010-08-300715 · Cited by 140

A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice.

Olee, T., Pierangeli, S. S., Handley, H. H., Le, D., Wei, X., Lai, C.-J., En, J., Novotny, W. F., Harris, E. N., Woods, V. L., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8606 · Cited by 80